Asia Research Results 2021

This Research, carried out at our Asia Leadership Retreat, offers valuable insight into the outlook and priorities of executives in Asia.

Key findings from Criticaleye's Asia Research:

  • 47% of leaders in Asia expect no loss of revenue due to COVID-19
  • 30% say their trading trajectory is unchanged by the pandemic
  • 73% of leaders need to improve the quality of strategic debate in the SLT
  • Digitisation is the number one priority for 2021
  • Communication and collaboration are the biggest challenges for regional leaders
  • 91% say business models are being disrupted

Click here for the Criticaleye podcast. In episode one of our Leadership with New Horizons series, Criticaleye CEO Matthew Blagg and Director of Content Marc Barber cover key themes for leaders and senior executives in 2021.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
The Boards' Cyber-Risk Compas...

In this insight, Criticaleye Retreat Partner Palo Alto Networks shares the 10 questions every director should ask to govern, fortify and strategise their organisation’s approach to cyber risk.

Click here to download this insight
The Price of Paralysis

Criticaleye lead Partner AlixPartners paints a stark picture of global volatility, economic fragility, geopolitical shocks and relentless market shifts, in its 2025 'Turnaround and Transformation...

Click here to download this insight
Practical AI for CEOs

AlixPartners’ Practical AI for CEOs playbook cuts through the hype to show how leaders can turn AI ambition into measurable business value. In a market defined by rapid innovation and intensifying competition, the...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 490




Worldpay Google IBM Consulting Workday Concentrix E.ON UK NatWest Group NATS Drax Group plc Legal & General Accenture Rolls-Royce Eightfold AI Salesforce AlixPartners British Land Aldermore Group Palo Alto Networks Hitachi Solutions Lightsource bp GlaxoSmithKline plc FTSE Women Leaders Review London Stock Exchange Group